Combination Therapy for the Treatment of Obstructive Sleep Apnea

Trial Profile

Combination Therapy for the Treatment of Obstructive Sleep Apnea

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 29 Jan 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Dec 2014.
    • 22 May 2013 Preliminary results for 5 patients presented at the 109th International Conference of the American Thoracic Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top